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gujk@mail.jlu.eduAbstract It is essential to develop effective methods for the quality control of the traditional
medicine with multiple components. However, few researches on the quality control have been
conducted to interpret the holistic characteristics of the traditional medicine in terms of dissolution/
release. In this study, the multi-component release kinetics of Traditional Chinese Medicine (TCM)
dosage forms was characterized and mapped by multivariate analysis techniques in the ﬁeld of
‘‘-omics’’. The Liuweidihuang pill was used as a model formulation. The multi-component release
kinetics of the concentrated and water-honeyed Liuweidihuang pills at rotation speeds of 50 and
100 rpm were analyzed by chemomic release kinetic theory and modiﬁed LC/MS/MS method.
Mass features of 103 (concentrated pills) and 101 (water-honeyed pills) were selected with a linear
correlation coefﬁcient Z0.99 between mass responses and concentrations. To compose the
chemomic standard spectrum, the relative abundance of both mass features was no less than 1%edica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and
rved.
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Characterization and mapping of TCM’s multi-component release kinetics 107as compared with an internal standard. The correlation coefﬁcients between six samples of various
solutions were in line with analytical requirements of precision (rZ0.985). The score plots of
principal component analysis showed that the concentrated Liuweidihuang pills presented better
chemomic release reproducibility than the water-honeyed pills. Conversely, the impact of rotation
speed on the chemomic release was less obvious. The heat maps of hierarchical clustering analysis
did not show signiﬁcant changes in individual clusters of mass features along different time
intervals, reﬂecting the release integrity of the mass features. Therefore, both multivariate analysis
methods, the principal component analysis and the hierarchical clustering analysis, seemed to be
effective techniques to demonstrate the multiple component release performance of TCM. The
research provided the basis of a new strategy for the quality control procedures of the dissolution/
release for the traditional medicine and multi-component natural products to address increasing
regulatory requirements and scrutiny across the world.
& 2011 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical
Association. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Traditional medicine has played an important role in main-
taining human health and improving the quality of human life
for thousands of years in China. Nowadays, about 80% of the
Asian and African population relies on traditional medicine
for at least part of their primary health care1. According to the
World Health Organization (WHO), traditional medicines
include herbal, Ayurveda, Siddha medicine, Unani, ancient
Iranian medicine, Islamic medicine, traditional Chinese med-
icine (TCM), acupuncture, Muti, and Ifa´1. As one of the most
important contributors to traditional medicine, TCM philo-
sophy not only considers single factors responsible for a
certain disease but also addresses the balance of the whole
organism (‘‘holism’’) and its interaction with the
environment2.
However, the characteristics of multiple components chal-
lenge the quality control for TCM-based pharmaceutical
products. Up to now, the application and modernization of
TCMs is still limited because of the lack of effective quality
control methods for products with multiple components3–5.
Furthermore, there is neither in vitro dissolution/release con-
trol nor in vivo pharmacokinetic data supporting for com-
pounded TCM agent yet. The dissolution/release tests are one
of the most important elements for the characterization of
solid oral dosage forms and drug delivery systems (DDS).
These tests are mainly used to conﬁrm product quality and
batch-to-batch consistency in order to optimize formulations
and process conditions for the dosage forms of chemical
pharmaceuticals. More importantly, the in vitro dissolution/
release tests also provide a basis for the correlation of in vitro
dissolution data with in vivo bioavailability, which would
beneﬁt the product development to a great extent6–8.
Therefore, it is necessary to develop a new method for the
recognition of the multi-component and ‘‘holistic’’ nature of
TCM, the key to the effective evaluation of the dissolution/
release performance of traditional dosage forms and DDS of
TCM. In the previous reports, we have proposed a new theory
and method for the release/dissolution kinetics of TCM based
on the overall characteristics of the chemome of the TCM9,10.
In this study, multivariate analysis methods in bioinformatics
and modern sciences named as ‘‘-omics’’, such as principalcomponent analysis (PCA) and hierarchical clustering analysis
(HCA), were applied to characterize and visualize the release
kinetics of TCMs. The Liuweidihuang pill, one of the most
known ancient Chinese herbal formulas, was used as a model
formulation.
The Liuweidihuang pill is widely used for the treatment of
various disorders, such as backache, alopecia, menoxenia, and
sore waist and knees. Recently, Liuweidihuang pills have been
reported to increase the number of T lymphocytes and
regulate the production of cytokines11,12. As a classic Chinese
herbal formula, Liuweidihuang pills are composed of
Rehmanniae Radix, Corni Fructus, Dioscoreae Rhizoma,
Alismatis Rhizoma, Poria and Paeoniae Suffruticosa Cortex.
Only two bioactive components in the pills, loganin and
paenol, are measured through current ofﬁcial quality control
practices. A number of methods have been developed for
the quantitative determination of bioactive components in
Liuweidihuang pills, such as HPLC–UV13,14, GC15, LC/MS/
MS16, MEKC17, and HPLC–DAD–ELSD18, but these
researches were all based on the determination of single
component(s), such as gallic acid, paeonol, ursolic acid,
loganin, and oleanolic acid, or a small number of components.
There is still no available compendial standard of quality
control on the release kinetics for all TCM solid dosage forms
(tablets, capsules, etc.) based on the TCM holistic principle.
In this study, the multi-component release performance of
Liuweidihuang pills was quantiﬁed through LC/MS/MS based
on chemomic release kinetics theory initially. The chemomic
release reproducibility of the components in Liuweidihuang
pills was characterized by score plots from PCA. The chemo-
mic release of Liuweidihuang pills was visualized through heat
maps from HCA.2. Theory development
The basic theory relating to the chemome and the standard
spectrum of the chemomic concentrations has been described
in detail in our previous articles9,10. Mass features with an
acceptable linearity (r40.99) were chosen to frame the
chemome. The term ‘‘chemome’’ was deﬁned as the assembly
of chemical compounds contained in the TCM preparation
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moieties of the components:
M ¼ ½M1 M2 M3   Mm1 Mm ð1Þ
where Mi denotes the amount of the ith compound whilst m
denotes the number of components. The standard spectrum of
the chemomic concentrations is referred to the assembly of the
chemical compound concentration in the solution of the TCM
preparation. In this paper, the standard spectrum of the
chemomic concentrations consisted of the ratio of the response
of each mass feature to the response of the internal standard
on LC/MS/MS spectrum. The chemomic concentration can be
represented by the term G, and the standard spectrum of
chemomic concentration (GS) is given by
GS ¼
Mi
V
¼ RS;1 RS;2 RS;3   RS;m1 RS;m
  ð2Þ
where R is the ratio of the response of each mass feature to the
response of the internal standard in the standard chemome
solution. The chemomic concentration GT is a characteristic
parameter obtained by comparing the chemomic spectrum of
the test sample to the chemomic standard spectrum:
GT ¼ ½RT ;1 RT ;2 RT ;3   RT ;m1 RT ;m ð3Þ
where R denotes the determined response value of each mass
feature.3. Materials and methods
3.1. Materials
The LC–MS/MS system consisted of an Agilent 1100 series
HPLC (Agilent Technologies, Palo Alto, CA, USA) and
Applied Biosystems Sciex API 4000 mass spectrometer (Applied
Biosystems/MDS Sciex, Concord, ON, Canada) using electro-
spray ionization (ESI). Concentrated Liuweidihuang pills (lot
number: 8072560) and water-honeyed Liuweidihuang pills (lot
number: 9030542) were obtained from Beijing Tong Ren Tang
Technologies Co., Ltd. (Beijing, China).3.2. Analytical methods
3.2.1. Stock solution
Sixteen concentrated Liuweidihuang pills (sixty for water-
honeyed pills) were precisely weighed and then thoroughly
comminuted to ensure complete mixing. Samples of the ﬁne
powders, equal to the average pill weight (eight for concen-
trated pills and thirty for water-honeyed pills), were weighed
and transferred to a dissolution beaker containing 900 mL
degassed distilled water. The paddle dissolution method was
then employed for 10 h. A sample of solution from the
dissolution vessel was ﬁltered using a 0.45 mm membrane,
and the standard chemomic stock solution was obtained by
diluting the ﬁltered solution with water at a ratio of 1:10. The
solution of standard reference substance diazepam with the
concentration of 100 ng/mL was prepared as the internal
standard solution.3.2.2. LC–MS/MS conditions
The chromatography elution was performed using 10 mmol/L
ammonium acetate in puriﬁed water as solvent A and
methanol as solvent B, with a ratio of 10:90 v/v. The ﬂow
rate was set at 0.2 mL/min. The injection volume was 20 mL.
ESI was performed in positive ion mode with nebulizer. The
ion spray needle voltage and heater gas temperature were set
at 3000 V and 400 1C, respectively. The pressure of GS1 and
GS2 was 40 psi in each case. The pressure of curtain gas was
15 psi. The MS acquisition was performed in Q1 full scan
mode (100–1000 amu).
3.2.3. Data collection
Data collection was performed under ‘‘LC–MS/MS conditions’’.
The full scan chromatography was recorded for 2.5 min. After
subtracting the background response within 1.6–2.2 min, the
data collected within 0.5–1.0 min was used for further analysis.
3.2.4. Standard series solution
Stock solutions with volumes of 1, 1.25 (solution A), 1.67, 2.5
(solution B), 5 and 10 mL (solution C) were transferred to
10 mL volumetric ﬂasks, and diluted to 10 mL with distilled
water as the standard series solutions.
3.2.5. Chemomic standard spectrum
100 mL of the stock solution and 100 mL of the internal standard
solution were precisely transferred and mixed. Samples with
20 mL of the mixed solutions were then analyzed according to
the operation procedure of ‘‘Section 3.2.3, Data collection’’. The
ratios of the response of all the mass features to the response of
the internal standard were recorded and exported.
3.2.6. Mass features selection
100 mL of the standard series solution and 100 mL of the
internal standard solution were precisely transferred and
mixed for the analysis of linearity. Samples with 20 mL of
the mixed solutions were analyzed according to the data
collection operation. The ratios of the response of all the
mass features to that of internal standard were exported. The
chemomic concentrations of individual standard series solu-
tions were obtained by comparison with the chemomic
standard spectrum. In order to meet the requirement of
LC/MS/MS quantitative analysis, mass features with a linear-
ity coefﬁcient value (r)Z0.99 were selected to construct the
chemomic standard spectrum.
3.2.7. Precision
Standard solutions of A, B and C were sampled and assayed
six times in parallel to evaluate the precision of the method by
correlation matrix analysis.
3.3. Determination of the chemomic release kinetics
The release kinetics of the components from the Liuweidihuang
pills was determined using the second dissolution method
detailed in Chinese pharmacopoeia 2010. Distilled water was
used as the dissolution medium and the temperature was set at
37 1C. Aliquots of 5 mL solution samples were collected at 20,
30, 60, 90, 120 and 180 min and 5 mL distilled water was added
immediately after collection of each sample solution. The sample
solution was ﬁltered through a 0.45 mm membrane, then
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accordingly to calculate the chemomic release kinetics. The
chemomic release kinetics at two different rotation speeds of
50 and 100 rpm were determined.4. Results and discussion
4.1. Mass features selection
To meet the requirement of subsequent quantitative analysis,
the MS responses of the chosen mass features in the standard
series solutions should be linear. Also, the correlation coefﬁ-
cient (r) of linear regression should be close to unity. There-
fore, mass features with rZ0.99 were selected to construct the
chemome. Mass features of 103 (m/z from 104.35 to 717.65)
and 101 (m/z from 104.35 to 869.95) were selected for
concentrated Liuweidihuang pills and water-honeyed pills,
respectively. The linearity of the chemomic concentration in
Liuweidihuang pills was appropriate for the release test.
4.2. Chemomic standard spectrum
In the chemomic standard spectrum, X-axis was m/z value of
individual mass feature and Y-axis was the ratio of the
response of each mass feature to that of internal standard
where the internal standard bar was set to be 100 (Fig. 1).
4.3. Precision
Owing to the multi-component characteristics of Liuweidi-
huang pills, the precision in our study was evaluated by
correlation matrix analysis, which is usually used to assess
the similarity of observations with multiple variables in
statistics. As shown in Table 1, the correlation coefﬁcients
between six samples of various solutions indicated that the
reproducibility of the analytical method met the requirement
of our study well (rZ0.985 for concentrated pills and rZ0.994
for water-honeyed pills).
4.4. Chemomic release kinetics
For dosage forms composed of single component, the release
kinetics was readily described by a dissolution curve, with theFigure 1 Chemomic standard spectrum of concentratedtime as X-axis and R (%, cumulative fraction of drug released)
as Y-axis. For the TCM dosage forms composed of multi-
components, three-dimensional graphs were employed to
represent the chemomic release kinetics. As shown in Fig. 2,
representative three-dimensional graphs were produced by
Sigmaplot software (Version 10.0, Systat Software, Inc.), with
the time as X-axis, mass feature (m/z) as Y-axis and the
relative cumulative release fraction as Z-axis. The contour
plots were provided at the top surfaces of the grids simulta-
neously. Similar to our previous study9,10, Kalman ﬁltering
was also employed to process the multiple component release
data whilst the chemomic concentration of the sample was
obtained. The chemomic release proﬁles were then plotted as
shown in Fig. 3A.
Based on the characteristics of multiple components for
TCM, the cumulative release percent of each mass feature at
any sampling time was a point in multidimensional space. The
distance between each point and the origin could be calculated
by the Euclidean distances equation. With an increase in
sampling time, the cumulative release percent of each mass
feature changed. The spatial position of each point also shifted
correspondingly. The shift tendency was similar to the cumu-
lative and increasing trend of multi-component release. Thus,
the distance between each point at any sampling time and the
origin exhibited the cumulative and increasing trend of multi-
component release (Fig. 3B). For the calculation of the
Euclidean distances, samples at different times were consid-
ered as the observations, and the cumulative release percen-
tage of each mass feature was considered as the characteristic
variable of the observations.
As shown in Figs. 2 and 3, the cumulative quantity of
chemome released and the distance values at 50 rpm for water-
honeyed pills were the smallest. For concentrated pills, three-
dimensional and distance curves at 50 and 100 rpm exhibited
no distinct differences. Thus, there was no obvious effect of
rotation speed on chemomic release kinetics of concentrated
Liuweidihuang pills. For water-honeyed pills, the cumulative
quantity of chemome released and distance value at 50 rpm
was smaller than that at 100 rpm, and thus the effect of
rotation speed on the chemomic release kinetics in this case
was considerable. Considering the reproducibility of the
chemomic release at different time points, or the release
variation of each mass feature during certain time intervals,
little information was gained from Figs. 2 and 3. Therefore,
the three-dimensional Kalman ﬁltered release proﬁles andLiuweidihuang pills (A) and water-honeyed pills (B).
Table 1 Correlation matrix to evaluate the method precision of LC–MS/MS analysis.
Concentrated pills Water-honeyed pills
L1 L2 L3 L4 L5 L6 L1 L2 L3 L4 L5 L6
L1 1 1
L2 0.989 1 0.997 1
L3 0.991 0.995 1 0.997 0.994 1
L4 0.990 0.996 0.993 1 0.997 0.997 0.997 1
L5 0.985 0.997 0.992 0.995 1 0.996 0.996 0.998 0.998 1
L6 0.986 0.997 0.992 0.996 0.997 1 0.997 0.995 0.997 0.997 0.997 1
M1 M2 M3 M4 M5 M6 M1 M2 M3 M4 M5 M6
M1 1 1
M2 0.999 1 0.998 1
M3 0.998 0.998 1 0.999 0.999 1
M4 0.997 0.997 0.999 1 0.999 0.998 0.999 1
M5 0.998 0.998 0.999 0.999 1 0.999 0.998 0.999 0.999 1
M6 0.998 0.998 0.999 0.999 0.999 1 0.998 0.997 0.999 0.999 0.999 1
H1 H2 H3 H4 H5 H6 H1 H2 H3 H4 H5 H6
H1 1 1
H2 0.997 1 1.000 1
H3 0.993 0.995 1 0.999 0.999 1
H4 0.996 0.995 0.998 1 0.999 1.000 1.000 1
H5 0.995 0.995 0.997 0.998 1 0.999 1.000 1.000 1.000 1
H6 0.993 0.992 0.996 0.998 0.998 1 0.999 0.999 1.000 1.000 1.000 1
L1–L6, M1–M6 and H1–H6 represent 6 duplicates of solutions a, b and c, respectively.
H
a
i-y
a
n
L
i
et
a
l.
1
1
0
Figure 3 Chemomic release proﬁles of Liuweidihuang pills obtained by the Kalman ﬁltering method (plot A) and the average distance
between each time point and time point of zero (plot B) (curve 1: 50 rpm for concentrated pills; curve 2: 100 rpm for concentrated pills; curve
3: 50 rpm for water-honeyed pills; curve 4: 100 rpm for water-honeyed pills; each point represented mean7S.D. of six determinations).
Figure 2 Three-dimensional plots of chemomic release of Liuweidihuang pills (plot A: 50 rpm for the concentrated pills; plot B: 100 rpm
for concentrated pills; plot C: 50 rpm for water-honeyed pills; plot D: 100 rpm for water-honeyed pills; each release proﬁle represented the
mean of six determinations).
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tionally, and failed to demonstrate the chemomic release
performance of all the individual components.4.5. Reproducibility of the chemomic release of
Liuweidihuang pills
Principal component analysis (PCA) is a useful technique for
the classiﬁcation of data and has been well reported for its
principles previously19. PCA reduces the dimensionality of a
data set (sample) by ﬁnding a new set of variables, which is
smaller than the original set of variables but retains most of
the information. The new variables, called principal compo-
nents (PCs), are uncorrelated and ordered by the fraction of
total information each retains. The ﬁrst principal component
accounts for as much of the variability in the data as possible,
and each succeeding component accounts for as much of the
remaining variability as possible. In PCA analysis, the score
plot provides the distribution and clustering of the samples
whilst the loading plot provides the distribution and clustering
of the variables. Thus, the PCA score plot was used in this
study to illustrate the reproducibility of the multiple compo-
nent release of Liuweidihuang pills.
Two data sets with 36 observations (six parallel chemomic
release samples of 0–20, 20–30, 30–60, 60–90, 90–120 and
120–180 min) were used for PCA analysis. The data set for
concentrated pills contains 103 independent variables and that
for water-honeyed pills contains 101 independent variables.
The PCA analysis was conducted using SIMCA-P software
(Umetrics AB, Umea, Sweden, demo version) on the abovedata sets for dissolution of the concentrated pills at 50 rpm,
concentrated pills at 100 rpm, water-honeyed pills at 50 rpm
and water-honeyed pills at 100 rpm. Outliers were determined
with a Hotelling’s test20. The time point zero was not included
in the computations since it contained no information (i.e. all
percentages dissolved are equal to zero), while it inﬂuenced the
number of degrees of freedom for building the limits. PCA
score plots are shown in Fig. 4A–D.
Each point on the score plot represented an individual
chemome released within certain time intervals and each point
on the loading plot represented a mass feature (data not
shown). For example, in Fig. 4A, points 1–7 represented the
chemome released within 0–20 min of six parallel operations.
If the chemome released within 0–20 min exhibited perfect
reproducibility, these seven points should overlap with each
other. In fact, ideal reproducibility did not exist and the points
were simply distributed closely. Therefore, the PCA score plot
was applied to evaluate the reproducibility of the chemome
released between different time intervals, rotation speeds and
preparations.
In Fig. 4, the seven orange points were located closely in all
the four ﬁgures (A–D). It indicated that the chemome released
within 0–20 min exhibited a relatively good reproducibility
regardless of different rotation speeds and preparations. The
chemome release performance within 0–20 min was stable and
inﬂuenced by neither rotation speed nor preparation type,
while the distributions of the other ﬁve groups (20–30, 30–60,
60–90, 90–120 and 120–180 min) were dramatically changed in
all four ﬁgures. This observation demonstrated that the
chemome released within these ﬁve time intervals exhibited
relatively poor reproducibility and thus the chemome release
Figure 4 PCA score plots of the release increment of Liuweidihuang
pills (plot A: 50 rpm for concentrated pills; plot B: 100 rpm for
concentrated pills; plot C: 50 rpm for water-honeyed pills; plot D:
100 rpm for water-honeyed pills; 1–6 (orange points) for six samples
in the range 0–20 min, 7–12 (black points) for 20–30 min, 13–18
(blue points) for 30–60 min, 19–24 (red points) for 60–90 min, 25–30
(purple points) for 90–120 min, 31–36 (green points) for 120–180 min;
the ellipse represented the 95% conﬁdence region).
Hai-yan Li et al.112performance within these time intervals was unstable and
inﬂuenced by the rotation speed or preparation type.
The effect of the preparation type on the chemomic release
was also clearly demonstrated from Fig. 4. The score plots of
concentrated Liuweidihuang pills (Fig. 4A and B) showed
more extensive separation of the six time interval groups thanwater-honeyed pills (Fig. 4C and D). Therefore, concentrated
Liuweidihuang pills presented better chemomic release repro-
ducibility than water-honeyed pills. This was probably asso-
ciated with the difference in preparation process between
concentrated pills and water-honeyed pills. The former was
prepared from the extracted solutions of the herbals while the
latter was prepared using the original powders made directly
from the herbals. On the other hand, the effect of rotation
speed during the dissolution test (50 and 100 rpm) on the
chemomic release was less obvious than that of the prepara-
tion type. For concentrated pills, the chemomic release
reproducibility of 90–120 and 120–180 min at 100 rpm was
better than that at 50 rpm, whilst the reproducibility for water-
honeyed pills was similar at the two different rotation speeds
tested.
The multi-component chemomic release kinetics was a
dynamically changing process. The PCA score plot also
depicted a time-related trajectory of samples. In Fig. 4, the
chemome released in different time intervals was diverse.
From the left hand side to the right hand side (along t [1]),
the level of the chemome released increased with the corre-
sponding time interval. The group of 0–20 min was located at
the right side along t [1], far away from the other points
(Fig. 4A–D). This indicated that the chemome released within
0–20 min was the largest of all the time intervals, which was
consistent with the results of Figs. 2 and 3. The location
tendency of the other ﬁve groups was uncertain in the above
four ﬁgures, illustrating the asynchronicity of the chemomic
release. In Fig. 4A (concentrated pills at 50 rpm), the rank
of the chemome released was 0–20430–60460–90¼120–
180420–30490–120 min. In Fig. 4B (concentrated pills at
100 rpm), the order was 0–20430–60420–30460–90¼120–
180490–120 min. The location of the 20–30 min group chan-
ged dramatically in the plot.4.6. Visualization of the chemomic release characteristics of
Liuweidihuang pills
In order to improve visualization and interpretation of the
chemomic release performance and generate a panorama
concerning the release variation of the mass features during
certain time intervals, a two-way unsupervised hierarchical
clustering analysis (HCA) was applied. In HCA, rows and
columns were clustered simultaneously to obtain groups as
similar as possible to produce results that are easily visualized
and interpreted21. HCA has been extensively used in the ﬁeld
of genomics, proteomics and metabonomics. Here, consider-
ing the common features between the multi-components for
TCMs and the omic sciences, it was applied to map the
chemomic release characteristics of TCM.
In this study, a two-way HCA was carried out using
PermutMatrix (version 1.9.3)22. The entire data set (36 103
or 36 101) was submitted for the two-way HCA, with the
rows of mass features and the columns of different time
intervals. Z-score transformation of rows normalization was
employed to ensure that the chemome released at each time
interval had a median value of 0 and a standard deviation of 1.
The analysis was carried out using the Euclidean distance as
the dissimilarity criterion for clustering and seriation, and
Ward’s method as the criterion for aggregation23. Then, a heat
map of the chemome released in different time intervals was
Figure 5 Hierarchically clustered heat map of the chemome released in six different time intervals (plot A: 50 rpm for concentrated pills;
plot B: 100 rpm for concentrated pills; plot C: 50 rpm for water-honeyed pills; plot D: 100 rpm for water-honeyed pills; row represents
mass features and column represents release increment of each mass feature at different observations; cells were colored based on release
increment; yellow indicates Z-scores40, blue indicates Z-scoreso0 and black indicates Z-scoresE0 of a row (mass feature) across all
columns (different time intervals)).
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component chemome. In the heat map generated by HCA,
each colored cell represented the chemome released at each
time interval according to the color scale at the top of the
ﬁgure. Fig. 5A–D depicted the hierarchically clustered heat
maps of the chemome released in six different time intervals
for concentrated Liuweidihuang pills and water-honeyed
Liuweidihuang pills at rotation speeds of 50 and 100 rpm.
The heat maps (Fig. 5) provided clusters of the columns
horizontally and the rows vertically. The heat maps also readily
showed changes in the chemomic release increments along
different clusters of columns (time intervals) and different
clusters of rows (mass features). Among the maps of
Fig. 5A–D, the columns of ‘‘0–20 min’’ were the best clustered,
agreed with the previous results from Fig. 4A. In Fig. 5A, six
time intervals were binned into approximately ﬁve clusters.
Except for the columns of ‘‘60–90 min’’, other ﬁve time
intervals were all well clustered. Likewise, in Fig. 5B, six time
intervals could be binned into approximately ﬁve clusters.
Apart from the columns of ‘‘120–180 min’’, the other ﬁve time
intervals were all well clustered. In Fig. 5C and D, the distances
between clusters were so short that it was very difﬁcult to bin
the time intervals into ﬁve clusters. Thus it could be concluded
that the columns of the six time intervals were mixed with each
other as shown in Fig. 5C and D, which are consistent with the
results and observations shown in Fig. 4A.
Three clusters of the rows were marked out in the heat
maps. As determined previously, the mass features of con-
centrated pills were different from those of water-honeyed
pills. Although the mass features were not identiﬁed qualita-
tively in this study, some useful information about the
clustering behavior of the mass features was obtained. In the
metabonomic research, the HCA was employed to cluster
mass features to discriminate the ‘‘metabolites signature’’. In
the heat maps of metabonomic research, biomarkers could beidentiﬁed. The altered concentration of the biomarkers in
different observations (columns) was noted and used to
discriminate the observations. Unlike the metabonomic
research, the heat maps in this study were used to show the
integrity and the synchronicity of the mass features and then
the holism of TCM. As expected, there were no major changes
in individual clusters of mass features along different time
intervals (Fig. 5A–D). This ﬁnding was a persuasive rationale
for the visualization of multi-component release by two-way
HCA. This method directly proved the integrity of the release
kinetics of multi-component TCMs.5. Conclusions
Based on the PCA techniques used in the ﬁeld of bioinfor-
matics and multivariate statistics, and HCA in the ﬁeld of
omics-named sciences, combined with LC/MS/MS and che-
momic release kinetic theory, the in vitro release characteristics
of the TCM dosage form, pills of Liuweidihuang prepared by
two different processes, were represented, assessed and visua-
lized directly. Novel techniques were employed in this research
to meet the requirement of multiple components consistent
with the holism of TCM. The correlation matrix was used to
evaluate the precision of the analysis; three-dimensional
graphs, the Kalman ﬁltering method and the Euclidean
distance were used to frame the tendency of the multiple
component release kinetic proﬁles in a simple and easy-to-read
approach; the PCA score plots were used to evaluate the
release reproducibility and the HCA heat map to visualize the
entire release proﬁles. It was indicated, in this research, that
these techniques provided new choices and new vision to the
delivery system design and quality control of dissolution/
release of TCM and other similar ethnic medicines with
multiple components.
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